This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Fetus and newborn affected by noxious influences transmitted via placenta or breast milk
P16_FET_NEWB_NOXIO_INFLUENCES_TRANSMIT_PLACEN_BREAST_MILK
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
34 |
4. Check minimum number of eventsNone |
34 |
5. Include endpointsNone |
34 |
6. Filter based on genotype QC (FinnGen only) |
34 |
Control definitions (FinnGen only)
- Control exclude
- P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P0[0-4]
- Name in latin
- Fetus et neonatus influentiis noxiis per placentam sive lac maternum translatis affectus
Similar endpoints
↥List of similar endpoints to
Fetus and newborn affected by noxious influences transmitted via placenta or breast milk
based on the number of shared cases.
Similar with more cases:
- Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery
- Certain conditions originating in the perinatal period
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3798 | 1782 | 2014 |
| Only index persons | 1275 | 630 | 645 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | 0.06 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 0.02 | 0.00 | 0.00 |
| Only index persons | 0.04 | 0.07 | 0.01 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 34 | 15 | 19 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 0.04 | 0.09 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
6
6
11.76
3.64
1.0
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
6
26
2.58
1.24
1.2
1.5
—
95.7
—
0
14
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
31
2.58
1.19
1.7
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
9
54
1.90
0.84
7.0
6.1
—
7.4
—
0
8
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
24
0.00
0.83
0.0
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
0
25
0.00
0.83
0.0
5.8
—
171.5
—
0
25
(36660697) Celiac disease serology panel - Serum
12
78
1.83
0.79
1.6
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
54
1.63
0.63
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
20
0.00
0.62
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
20
0.00
0.62
0.0
1.4
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
19
0.00
0.62
0.0
6.9
—
2.9
—
0
19
(1761868) Lipid panel - Serum or Plasma
0
22
0.00
0.61
0.0
3.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
116
0.59
0.59
1.6
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
19
153
1.55
0.52
2.6
2.1
—
—
—
0
0
(3015736) pH of Urine
12
88
1.56
0.48
9.8
5.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
8
56
1.56
0.47
1.4
1.5
u/ml
127.0
129.5
—
8
49
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5
30
1.78
0.46
2.0
2.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
8
60
1.43
0.44
3.3
3.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
12
90
1.52
0.43
2.4
5.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
5
33
1.60
0.43
2.0
2.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
0
15
0.00
0.42
0.0
18.3
—
0.3
—
0
10
(3002523) Influenza virus A Ag [Presence] in Specimen
0
15
0.00
0.42
0.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
15
0.00
0.42
0.0
1.1
—
179.4
—
0
5
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
15
0.00
0.42
0.0
1.3
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
0
16
0.00
0.42
0.0
2.6
—
0.1
—
0
10
(3021387) Prolactin [Units/volume] in Serum or Plasma
0
16
0.00
0.42
0.0
1.7
—
320.7
—
0
16
(3011897) Casein IgE Ab [Units/volume] in Serum
0
17
0.00
0.42
0.0
1.6
—
1.6
—
0
7
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.42
0.0
1.8
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
17
0.00
0.42
0.0
1.2
—
1.7
—
0
10
(3018677) aPTT in Platelet poor plasma by Coagulation assay
5
76
0.60
0.41
4.4
10.3
s
32.0
31.6
—
5
76
(40761511) CBC panel - Blood by Automated count
29
266
1.61
0.41
9.7
11.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
21
180
1.44
0.38
18.0
21.4
mmol/l
1.2
1.2
0.01
21
173
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
21
180
1.44
0.38
14.9
20.2
mmol/l
1.2
1.2
0.08
21
170
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
28
295
0.71
0.36
4.7
4.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
7
53
1.40
0.33
7.9
5.5
—
1.0
—
0
18
(3001122) Ferritin [Mass/volume] in Serum or Plasma
15
123
1.39
0.33
4.0
4.8
ug/l
39.1
52.3
0.31
15
117
(3022313) Gas panel - Capillary blood
14
114
1.39
0.32
7.2
12.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
13
105
1.39
0.31
19.7
16.9
g/l
37.4
36.7
0.18
13
100
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
5
70
0.67
0.30
10.4
5.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
9
74
1.29
0.28
2.0
4.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
17
147
1.31
0.25
8.5
6.8
u/l
242.4
193.4
0.73
17
138
(40760892) CBC W Ordered Manual Differential panel - Blood
6
48
1.30
0.22
9.7
10.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
11
0.00
0.22
0.0
2.7
—
11.3
—
0
11
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
0
11
0.00
0.22
0.0
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
11
0.00
0.22
0.0
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
11
0.00
0.22
0.0
1.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
10
0.00
0.22
0.0
5.2
—
1.5
—
0
10
(3016038) Potassium [Moles/volume] in Urine
0
10
0.00
0.22
0.0
2.5
—
27.9
—
0
10
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.22
0.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
0
10
0.00
0.22
0.0
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
10
0.00
0.22
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.22
0.0
5.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.22
0.0
5.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
10
0.00
0.22
0.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
10
0.00
0.22
0.0
2.6
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
0
10
0.00
0.22
0.0
2.7
—
4.4
—
0
5
(3051611) Lipemic interference index of Serum or Plasma
0
10
0.00
0.22
0.0
3.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
10
0.00
0.22
0.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
10
0.00
0.22
0.0
3.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
0
10
0.00
0.22
0.0
2.8
—
5.1
—
0
10
(3000093) Morphology [Interpretation] in Blood Narrative
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
6
49
1.27
0.21
4.3
6.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.9
—
3.2
—
0
13
(3003740) Influenza virus B Ag [Presence] in Specimen
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
14
0.00
0.20
0.0
22.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
7
61
1.19
0.19
31.9
30.1
mg/l
1.2
1.0
—
7
61
(3020961) Endomysium IgA Ab [Titer] in Serum
5
64
0.74
0.19
2.2
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
10
83
1.29
0.18
2.1
5.4
—
—
—
0
0
(3044889) 12 lead EKG panel
7
86
0.77
0.17
2.1
2.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
26
246
1.24
0.16
12.7
14.2
u/l
20.4
25.2
1.29
26
239
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
10
115
0.82
0.13
3.5
4.8
mmol/l
4.1
4.2
—
10
110
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
10
115
0.82
0.13
3.5
4.2
mmol/l
1.2
1.4
—
10
106
(42870588) Differential panel, method unspecified - Blood
22
205
1.21
0.12
8.5
14.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
15
165
0.84
0.12
2.1
2.1
g/l
0.9
1.1
—
6
70
(3037467) Urinalysis macro (dipstick) panel - Urine
16
175
0.84
0.12
9.0
6.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
10
114
0.83
0.11
3.5
4.4
mmol/l
2.6
2.6
—
10
108
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
13
144
0.84
0.11
13.5
16.1
mmol/l
24.6
24.9
0.24
13
144
(3028626) Oxygen [Partial pressure] in Capillary blood
13
117
1.18
0.10
7.8
13.3
kpa
10.6
10.0
0.44
13
112
(36304419) Bacteria [Presence] in Urine
13
117
1.18
0.10
7.4
6.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
7
64
1.12
0.09
1.3
2.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
10
91
1.14
0.05
11.1
4.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
13
126
1.05
0.00
18.1
14.7
mmol/l
1.5
1.4
0.19
13
120
(3000991) Gas panel - Venous blood
12
124
0.95
0.00
13.9
14.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
13
131
0.99
0.00
11.0
7.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
17
168
1.02
0.00
13.8
13.5
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
17.0
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
0
7
0.00
0.00
0.0
9.3
—
4.9
—
0
7
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
110.8
—
0
5
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
145.7
—
0
7
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.6
—
9.8
—
0
5
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
428.4
—
0
5
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
7
0.00
0.00
0.0
3.1
—
214.6
—
0
7
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
67.4
—
0
5
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
28.7
—
0
5
(3016031) Almond IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
3.7
—
0
5
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
0
7
0.00
0.00
0.0
9.3
—
10.0
—
0
7
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
4.4
—
4.4
—
0
7
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
5
0.00
0.00
0.0
8.8
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4268621)
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
0
8
0.00
0.00
0.0
3.0
—
166.1
—
0
8
(3024471) HLA-A [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
7.3
—
0
8
(3003694) ABO and Rh group [Type] in Blood
8
81
0.98
0.00
1.1
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
28
282
0.96
0.00
14.9
16.6
mg/l
15.4
23.9
1.58
19
187
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
76.5
—
0
8
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(4198724)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
305.1
—
0
8
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
7.1
—
7.4
—
0
9
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
31.7
—
0.7
—
0
6
(3020564) Creatinine [Moles/volume] in Serum or Plasma
26
258
1.03
0.00
15.1
15.5
umol/l
48.8
44.2
0.45
26
258
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.7
—
1.1
—
0
9
(3024932) HLA-DR beta [Type]
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
4.0
—
—
—
0
0
(4027681)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_FET_NEWB_NOXIO_INFLUENCES_TRANSMIT_PLACEN_BREAST_MILK and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have P16_FET_NEWB_NOXIO_INFLUENCES_TRANSMIT_PLACEN_BREAST_MILK.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: P16_FET_NEWB_NOXIO_INFLUENCES_TRANSMIT_PLACEN_BREAST_MILK – Fetus and newborn affected by noxious influences transmitted via placenta or breast milk
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data